To expand our understanding of LOXL2 in human tumours we utilised cBioPortal (www.cbioportal.org, accessed on 23 June 2023) to analyse the large TCGA PanCancer Atlas [51], which provides genetic information for 10,953 tumour samples to identify LOXL2 genetic alterations (Dataset S2). Here, LOXL2 is linked to neoplasm.